Clinical Trial Update: A Study to Assess the Anti-viral Activity, Safety, Tolerability and Pharmacokinetics of TMC435350 in Participants Infected With Hepatitis C-Virus (HCV) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating antiviral activity, safety, tolerability and pharmacokinetics of TMC435350 in participants with hepatitis C; study completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TMC435350

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2014-07-28